Clinical Trials of Metastatic Castration-sensitive Prostate Cancer

Recent Progress and New Horizons

Anis A. Hamid, Michael J. Morris, Ian D. Davis

Research output: Contribution to journalArticleOtherpeer-review

Abstract

Recent clinical trials have changed the treatment landscape for metastatic castration-sensitive prostate cancer. Ongoing and future studies using new therapeutic approaches hold the promise of further improving outcomes for patients with advanced prostate cancer.

Original languageEnglish
Pages (from-to)165-167
Number of pages3
JournalEuropean Urology Focus
Volume5
Issue number2
DOIs
Publication statusPublished - 1 Mar 2019

Cite this

@article{11363bd098df406e90b66a7bec687f7d,
title = "Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New Horizons",
abstract = "Recent clinical trials have changed the treatment landscape for metastatic castration-sensitive prostate cancer. Ongoing and future studies using new therapeutic approaches hold the promise of further improving outcomes for patients with advanced prostate cancer.",
author = "Hamid, {Anis A.} and Morris, {Michael J.} and Davis, {Ian D.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.euf.2018.12.001",
language = "English",
volume = "5",
pages = "165--167",
journal = "European Urology Focus",
issn = "2405-4569",
publisher = "European Association of Urology",
number = "2",

}

Clinical Trials of Metastatic Castration-sensitive Prostate Cancer : Recent Progress and New Horizons. / Hamid, Anis A.; Morris, Michael J.; Davis, Ian D.

In: European Urology Focus, Vol. 5, No. 2, 01.03.2019, p. 165-167.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Clinical Trials of Metastatic Castration-sensitive Prostate Cancer

T2 - Recent Progress and New Horizons

AU - Hamid, Anis A.

AU - Morris, Michael J.

AU - Davis, Ian D.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Recent clinical trials have changed the treatment landscape for metastatic castration-sensitive prostate cancer. Ongoing and future studies using new therapeutic approaches hold the promise of further improving outcomes for patients with advanced prostate cancer.

AB - Recent clinical trials have changed the treatment landscape for metastatic castration-sensitive prostate cancer. Ongoing and future studies using new therapeutic approaches hold the promise of further improving outcomes for patients with advanced prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=85058368177&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2018.12.001

DO - 10.1016/j.euf.2018.12.001

M3 - Article

VL - 5

SP - 165

EP - 167

JO - European Urology Focus

JF - European Urology Focus

SN - 2405-4569

IS - 2

ER -